A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology—boosting ...

In a study published today in JAMA Open Network, researchers claim the system is "boosting productivity, identifying ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from a Phase ...

Digital innovations such as ePRO and eCOA are streamlining clinical trials, boosting participant engagement, and improving ...

Sobi® (STO: SOBI) and Apellis Pharmaceuticals, Inc. today presented new data from the open-label period of the Phase 3 VALIANT study, investigating Aspaveli® ...

SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...

Kymera Therapeutics reported positive results from its phase 1 healthy volunteer study using KT-621. Click here to find out ...

Subtle symptoms of MS are often overlooked in patients with minimal disability, but clinical tools can help detect them early ...

Pediatric dermatologists reported they are not fairly compensated for educating primary care residents and struggle to ...

Circulating tumor DNA (ctDNA) testing has the potential to dramatically impact our approach to cancer management. This minimally invasive test, with potential for repeated testing, can track dynamic ...